The Fanconi anaemia/BRCA pathway.

Nat Rev Cancer

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA.

Published: January 2003

Fanconi anaemia (FA) is a rare genetic cancer-susceptibility syndrome that is characterized by congenital abnormalities, bone-marrow failure and cellular sensitivity to DNA crosslinking agents. Seven FA-associated genes have recently been cloned, and their products were found to interact with well-known DNA-damage-response proteins, including BRCA1, ATM and NBS1. The FA proteins could therefore be involved in the cell-cycle checkpoint and DNA-repair pathways. Recent studies implicate the FA proteins in the process of repairing chromosome defects that occur during homologous recombination, and disruption of the FA genes results in chromosome instability--a common feature of many human cancers.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc970DOI Listing

Publication Analysis

Top Keywords

fanconi anaemia/brca
4
anaemia/brca pathway
4
pathway fanconi
4
fanconi anaemia
4
anaemia rare
4
rare genetic
4
genetic cancer-susceptibility
4
cancer-susceptibility syndrome
4
syndrome characterized
4
characterized congenital
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!